Young Jonathan

CIK 00017798051 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001779805

Recent Transactions

28 trades

Gift
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-26−9,259→ 200,189 total
Gift
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-26−9,259→ 200,189 total
Gift
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-26−9,259→ 200,189 total
Gift
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-26−9,259→ 200,189 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.09/sh+4,284→ 201,182 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$28.35/sh+3,527→ 204,709 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.10/sh+4,739→ 209,448 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.09/sh+4,284→ 201,182 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$28.35/sh+3,527→ 204,709 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.10/sh+4,739→ 209,448 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.09/sh+4,284→ 201,182 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$28.35/sh+3,527→ 204,709 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.10/sh+4,739→ 209,448 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.09/sh+4,284→ 201,182 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$28.35/sh+3,527→ 204,709 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-24$21.10/sh+4,739→ 209,448 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-24−4,284→ 0 total

Companies

Akero Therapeutics, Inc.
Chief Operating Officer
$AKRO

Recent Filings

4
Young Jonathan
Nov 26, 2025

Address

C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov